BNTC News and Press, Benitec Biopharma Limited From 04/18/24

A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...

2024-04-18 08:55:05 ET More on Benitec Netflix, Johnson & Johnson, Procter & Gamble And Baidu On Watch Benitec Biopharma jumps 33% on $40M private financing Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Fi...

2024-04-18 08:06:51 ET DENVER, Colo., Apr 18, 2024 ( 247marketnews.com )- Benitec Biopharma Inc. (NASDAQ: BNTC ) reported positive interim clinical data and a private investment from the sale of 5,749,152 shares of its common stock at a price per share of $4.80 and 2,584,239 pre-fun...

-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements across multiple measures of swallowing function in the first Phase 1b/2a clinical study subje...

2024-04-18 07:14:34 ET More on Benitec Netflix, Johnson & Johnson, Procter & Gamble And Baidu On Watch Seeking Alpha’s Quant Rating on Benitec Historical earnings data for Benitec Read the full article on Seeking Alpha For further detai...

HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...

2024-04-14 07:51:01 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Read the full article on Seeking Alpha For further details see: Wall Street Breakfast: The Week Ahead

2024-04-13 10:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...

2024-04-12 15:00:09 ET More on the markets SPY: The Correction May Be Massive S&P 500: International Risk Assessment My Current View Of The Market: April 2024 Edition (Technical Analysis) Small business optimism hits 11-year low as stock bulls keep runnin...

HAYWARD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...